John Fieldly

CEO John Fieldly buys 8,475 shares of CELH at $29.36 amid -55.5% decline from 52-week high

John Fieldly, Chief Executive Officer, purchased 8,475 shares on 2026-05-22 at $29.36, increasing his holdings to 937,540 shares. The purchase occurs as CELH trades -55.5% below its 52-week high of $66.74 and has declined -41.4% over the past 90 days. Fieldly's cross-ticker track record shows a 50.00% well-timed rate on 10 prior sells with +6.4% average 90-day return, indicating mixed timing acumen. His same-ticker history at CELH shows 5 prior sales, 2 of which were well-timed at the 90-day mark; notably, 3 of those 5 sales captured gains of +14.0%, +2.9%, and +4.9% within 30 days, suggesting pattern recognition of near-term peaks. The purchase scale is modest (+0.9% of pre-transaction holdings), and the company reports strong fundamentals with +85.5% annual revenue growth and $110.1M net income on $782.6M quarterly revenue, though the P/E of 43.63 remains elevated despite current price weakness.

CEO John Fieldly sold 143,167 shares of CELH at $51.18 under 10b5-1 plan; post-sale holdings: 895,410 shares

Fieldly John, Chief Executive Officer of Celsius Holdings, sold 143,167 shares at $51.18 on 2025-08-07 for a total value of $7,327,287.06. This transaction is part of a pre-arranged 10b5-1 trading plan adopted on 2025-03-07, meaning the sale was scheduled rather than discretionary. Post-transaction, Fieldly retains 895,410 shares, representing a reduction of 143,167 shares or 13.8% of his pre-transaction holdings of 1,038,577 shares. As a 10b5-1 plan execution, this transaction reflects a pre-planned divestment schedule established months in advance, not a response to current market conditions or company performance.

CEO John Fieldly sold 130,803 shares of CELH at $45.00 on 2025-06-24 via pre-arranged 10b5-1 plan; retains 1,038,577 shares.

John Fieldly, CEO of Celsius Holdings, sold 130,803 shares at $45.00 totaling $5,886,135.00 pursuant to a 10b5-1 trading plan adopted on 2025-03-07. This was a scheduled, non-discretionary transaction, meaning the timing and volume were pre-determined months in advance and cannot be read as a contemporaneous signal about the stock or company outlook. Post-transaction, Fieldly retains 1,038,577 shares, down from 1,169,380 shares before the sale—a reduction of approximately 11.2% of his prior holdings. The sale's scale and the pre-arrangement framework preclude attribution of timing motive or conviction shift to this specific execution.

CEO Fieldly John sold 132,171 shares of CELH at $43.06 under pre-arranged 10b5-1 plan adopted 2025-03-07

Fieldly John, CEO of Celsius Holdings, executed a sale of 132,171 shares at $43.06 on 2025-06-10 for a total value of $5,691,283.26, reducing his holdings from 1,301,551 shares to 1,169,380 shares. This transaction is part of a pre-arranged 10b5-1 trading plan adopted on 2025-03-07, meaning it was scheduled in advance and not a discretionary response to current market conditions. As a CEO sale of this magnitude, the transaction represents a -10.2% reduction in his shareholdings, warranting investor monitoring of whether additional scheduled dispositions are planned under the same trading plan.

CEO John Fieldly sold 626,268 shares for $21,401,807.16 across two trades (Sept 12-13); post-sale holdings 1,261,069 shares (-33.2%)

CEO John Fieldly executed 2 separate sales totaling 626,268 shares for $21,401,807.16 on September 12-13 at an average price of $34.17, reducing his stake by 33.2% versus pre-transaction holdings. The blended sale price exceeds the current $33.18 price, and the CEO retains 1,261,069 shares post-transaction. At this same ticker (CELH), his prior 5 sales show mixed timing: 2 of 5 were well-timed at the 90-day mark, suggesting inconsistent predictive accuracy. The company is operationally strong with 101.6% annual revenue growth, $402.0M latest quarterly revenue, $79.8M net income, and P/E of 26.54; the material scale of this divestiture (over $21M) stands out relative to the company's $7.7B market cap and warrants examination of whether it reflects scheduled portfolio management or a shift in the CEO's position sizing at the holding.